Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: genetic Clear Filter

Biologists Uncover Previously Unknown Structure Hiding Inside Human Cells

Even after decades of peering into cells, biologists are still finding surprises. In a twist, researchers at the University of Virginia and the National Institutes of Health uncovered a new organelle, dubbed the hemifusome. This tiny membrane-bound structure serves as a cellular recycling center and may hold the key to treating several genetic diseases. The research has been published in Nature Communications. “This is like discovering a new recycling center inside the cell,” co-author Seham E

UK watchdog fines 23andMe over 2023 data breach

In Brief The U.K. data protection watchdog has fined 23andMe £2.31 million ($3.1m) for failing to protect U.K. residents’ personal and genetic data prior to its 2023 data breach. The Information Commissioner’s Office (ICO) said on Tuesday it has fined the genetic testing company as it “did not have additional verification steps for users to access and download their raw genetic data” at the time of its cyberattack. In 2023, hackers stole private data on more than 6.9 million users’ over a mon

Anne Wojcicki’s nonprofit reaches deal to acquire 23andMe

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to a nonprofit led by the company’s co-founder and former CEO Anne Wojcicki. Following a massive cyberattack in 2023 and a related lawsuit settlement, 23andMe filed for bankruptcy in March, with Wojcicki resigning in order to become an independent bidder for the company. But pharmaceutical company Regeneron was announced as the company’s acquirer with a $256 million bid. According to th

Congress Demands Answers on Data Privacy Ahead of 23andMe Sale

US Reps. Alexandria Ocasio-Cortez and Jan Schakowsky on Thursday sent letters to the two potential buyers of troubled genetic testing firm 23andMe demanding details about consumer data privacy should either of them acquire the company. Signed by 20 other Democratic members of Congress, the letters were sent to Regeneron Pharmaceuticals and TTAM Research Institute, which have put forth separate bids to buy 23andMe. In the letters, they ask Regeneron and TTAM if they will continue to give custome